カテゴリ： 世界, 医療/バイオ, QYResearch

単純疱疹治療の世界市場インサイト・予測（～2028年）

■ 英語タイトル：Global Cold Sore Treatment Market Insights, Forecast to 2028

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QY22JL3477）■ 発行会社/調査会社：QYResearch
■ 商品コード：QY22JL3477
■ 発行日：2022年7月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：127
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[単純疱疹治療の世界市場インサイト・予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

COVID-19のパンデミックにより、単純疱疹治療のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に単純疱疹治療の世界市場のxxx％を占める「抗ウイルス剤」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院薬局」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
単純疱疹治療の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの単純疱疹治療市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

単純疱疹治療のグローバル主要企業には、GlaxoSmithKline、Ortho Dermatologics、Foundation Consumer Healthcare、Novartis、Teva Pharmaceuticals、Amneal Pharmaceuticals LLC、AiCuris、Apotex、Aurobindo Pharma USA, Inc.、Cipla、Glenmark Pharmaceuticals, Inc.、Hikma Pharmaceuticals、HRA Pharma、Hetero Healthcare Ltd、Jubilant Cadista、Merix Pharmaceutical Corp、Square、Sun Pharmaceutical Industries Ltd.、Viatris、Wockhardt、Zydus Pharmaceuticalsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

単純疱疹治療市場は、種類と用途によって区分されます。世界の単純疱疹治療市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
抗ウイルス剤、鎮痛剤、その他

【用途別セグメント】
病院薬局、オンライン薬局、小売薬局

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 単純疱疹治療製品概要
- 種類別市場（抗ウイルス剤、鎮痛剤、その他）
- 用途別市場（病院薬局、オンライン薬局、小売薬局）
- 調査の目的
・エグゼクティブサマリー
- 世界の単純疱疹治療販売量予測2017-2028
- 世界の単純疱疹治療売上予測2017-2028
- 単純疱疹治療の地域別販売量
- 単純疱疹治療の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別単純疱疹治療販売量
- 主要メーカー別単純疱疹治療売上
- 主要メーカー別単純疱疹治療価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（抗ウイルス剤、鎮痛剤、その他）
- 単純疱疹治療の種類別販売量
- 単純疱疹治療の種類別売上
- 単純疱疹治療の種類別価格
・用途別市場規模（病院薬局、オンライン薬局、小売薬局）
- 単純疱疹治療の用途別販売量
- 単純疱疹治療の用途別売上
- 単純疱疹治療の用途別価格
・北米市場
- 北米の単純疱疹治療市場規模（種類別、用途別）
- 主要国別の単純疱疹治療市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの単純疱疹治療市場規模（種類別、用途別）
- 主要国別の単純疱疹治療市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の単純疱疹治療市場規模（種類別、用途別）
- 主要国別の単純疱疹治療市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の単純疱疹治療市場規模（種類別、用途別）
- 主要国別の単純疱疹治療市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの単純疱疹治療市場規模（種類別、用途別）
- 主要国別の単純疱疹治療市場規模（トルコ、サウジアラビア）
・企業情報
GlaxoSmithKline、Ortho Dermatologics、Foundation Consumer Healthcare、Novartis、Teva Pharmaceuticals、Amneal Pharmaceuticals LLC、AiCuris、Apotex、Aurobindo Pharma USA, Inc.、Cipla、Glenmark Pharmaceuticals, Inc.、Hikma Pharmaceuticals、HRA Pharma、Hetero Healthcare Ltd、Jubilant Cadista、Merix Pharmaceutical Corp、Square、Sun Pharmaceutical Industries Ltd.、Viatris、Wockhardt、Zydus Pharmaceuticals
・産業チェーン及び販売チャネル分析
- 単純疱疹治療の産業チェーン分析
- 単純疱疹治療の原材料
- 単純疱疹治療の生産プロセス
- 単純疱疹治療の販売及びマーケティング
- 単純疱疹治療の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 単純疱疹治療の産業動向
- 単純疱疹治療のマーケットドライバー
- 単純疱疹治療の課題
- 単純疱疹治療の阻害要因
・主な調査結果

Market Analysis and Insights: Global Cold Sore Treatment Market
The global Cold Sore Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Antiviral Agents accounting for % of the Cold Sore Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals Pharmacy segment is altered to an % CAGR throughout this forecast period.
China Cold Sore Treatment market size is valued at US$ million in 2021, while the North America and Europe Cold Sore Treatment are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Cold Sore Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cold Sore Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cold Sore Treatment market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cold Sore Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cold Sore Treatment market.
Global Cold Sore Treatment Scope and Market Size
Cold Sore Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Cold Sore Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Antiviral Agents
Analgesic Agents
Others
Segment by Application
Hospitals Pharmacy
Online Pharmacy
Retail Pharmacy
By Company
GlaxoSmithKline
Ortho Dermatologics
Foundation Consumer Healthcare
Novartis
Teva Pharmaceuticals
Amneal Pharmaceuticals LLC
AiCuris
Apotex
Aurobindo Pharma USA, Inc.
Cipla
Glenmark Pharmaceuticals, Inc.
Hikma Pharmaceuticals
HRA Pharma
Hetero Healthcare Ltd
Jubilant Cadista
Merix Pharmaceutical Corp
Square
Sun Pharmaceutical Industries Ltd.
Viatris
Wockhardt
Zydus Pharmaceuticals
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

*** レポート目次（コンテンツ）***

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cold Sore Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Antiviral Agents
1.2.3 Analgesic Agents
1.2.4 Others
1.3 Market by Application
1.3.1 Global Cold Sore Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals Pharmacy
1.3.3 Online Pharmacy
1.3.4 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cold Sore Treatment Market Perspective (2017-2028)
2.2 Cold Sore Treatment Growth Trends by Region
2.2.1 Cold Sore Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cold Sore Treatment Historic Market Size by Region (2017-2022)
2.2.3 Cold Sore Treatment Forecasted Market Size by Region (2023-2028)
2.3 Cold Sore Treatment Market Dynamics
2.3.1 Cold Sore Treatment Industry Trends
2.3.2 Cold Sore Treatment Market Drivers
2.3.3 Cold Sore Treatment Market Challenges
2.3.4 Cold Sore Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cold Sore Treatment Players by Revenue
3.1.1 Global Top Cold Sore Treatment Players by Revenue (2017-2022)
3.1.2 Global Cold Sore Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Cold Sore Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cold Sore Treatment Revenue
3.4 Global Cold Sore Treatment Market Concentration Ratio
3.4.1 Global Cold Sore Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cold Sore Treatment Revenue in 2021
3.5 Cold Sore Treatment Key Players Head office and Area Served
3.6 Key Players Cold Sore Treatment Product Solution and Service
3.7 Date of Enter into Cold Sore Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cold Sore Treatment Breakdown Data by Type
4.1 Global Cold Sore Treatment Historic Market Size by Type (2017-2022)
4.2 Global Cold Sore Treatment Forecasted Market Size by Type (2023-2028)
5 Cold Sore Treatment Breakdown Data by Application
5.1 Global Cold Sore Treatment Historic Market Size by Application (2017-2022)
5.2 Global Cold Sore Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cold Sore Treatment Market Size (2017-2028)
6.2 North America Cold Sore Treatment Market Size by Type
6.2.1 North America Cold Sore Treatment Market Size by Type (2017-2022)
6.2.2 North America Cold Sore Treatment Market Size by Type (2023-2028)
6.2.3 North America Cold Sore Treatment Market Share by Type (2017-2028)
6.3 North America Cold Sore Treatment Market Size by Application
6.3.1 North America Cold Sore Treatment Market Size by Application (2017-2022)
6.3.2 North America Cold Sore Treatment Market Size by Application (2023-2028)
6.3.3 North America Cold Sore Treatment Market Share by Application (2017-2028)
6.4 North America Cold Sore Treatment Market Size by Country
6.4.1 North America Cold Sore Treatment Market Size by Country (2017-2022)
6.4.2 North America Cold Sore Treatment Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Cold Sore Treatment Market Size (2017-2028)
7.2 Europe Cold Sore Treatment Market Size by Type
7.2.1 Europe Cold Sore Treatment Market Size by Type (2017-2022)
7.2.2 Europe Cold Sore Treatment Market Size by Type (2023-2028)
7.2.3 Europe Cold Sore Treatment Market Share by Type (2017-2028)
7.3 Europe Cold Sore Treatment Market Size by Application
7.3.1 Europe Cold Sore Treatment Market Size by Application (2017-2022)
7.3.2 Europe Cold Sore Treatment Market Size by Application (2023-2028)
7.3.3 Europe Cold Sore Treatment Market Share by Application (2017-2028)
7.4 Europe Cold Sore Treatment Market Size by Country
7.4.1 Europe Cold Sore Treatment Market Size by Country (2017-2022)
7.4.2 Europe Cold Sore Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cold Sore Treatment Market Size (2017-2028)
8.2 Asia-Pacific Cold Sore Treatment Market Size by Type
8.2.1 Asia-Pacific Cold Sore Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Cold Sore Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Cold Sore Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Cold Sore Treatment Market Size by Application
8.3.1 Asia-Pacific Cold Sore Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Cold Sore Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Cold Sore Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Cold Sore Treatment Market Size by Region
8.4.1 Asia-Pacific Cold Sore Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Cold Sore Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cold Sore Treatment Market Size (2017-2028)
9.2 Latin America Cold Sore Treatment Market Size by Type
9.2.1 Latin America Cold Sore Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Cold Sore Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Cold Sore Treatment Market Share by Type (2017-2028)
9.3 Latin America Cold Sore Treatment Market Size by Application
9.3.1 Latin America Cold Sore Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Cold Sore Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Cold Sore Treatment Market Share by Application (2017-2028)
9.4 Latin America Cold Sore Treatment Market Size by Country
9.4.1 Latin America Cold Sore Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Cold Sore Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cold Sore Treatment Market Size (2017-2028)
10.2 Middle East & Africa Cold Sore Treatment Market Size by Type
10.2.1 Middle East & Africa Cold Sore Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Cold Sore Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Cold Sore Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Cold Sore Treatment Market Size by Application
10.3.1 Middle East & Africa Cold Sore Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Cold Sore Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Cold Sore Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Cold Sore Treatment Market Size by Country
10.4.1 Middle East & Africa Cold Sore Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Cold Sore Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Cold Sore Treatment Introduction
11.1.4 GlaxoSmithKline Revenue in Cold Sore Treatment Business (2017-2022)
11.1.5 GlaxoSmithKline Recent Developments
11.2 Ortho Dermatologics
11.2.1 Ortho Dermatologics Company Details
11.2.2 Ortho Dermatologics Business Overview
11.2.3 Ortho Dermatologics Cold Sore Treatment Introduction
11.2.4 Ortho Dermatologics Revenue in Cold Sore Treatment Business (2017-2022)
11.2.5 Ortho Dermatologics Recent Developments
11.3 Foundation Consumer Healthcare
11.3.1 Foundation Consumer Healthcare Company Details
11.3.2 Foundation Consumer Healthcare Business Overview
11.3.3 Foundation Consumer Healthcare Cold Sore Treatment Introduction
11.3.4 Foundation Consumer Healthcare Revenue in Cold Sore Treatment Business (2017-2022)
11.3.5 Foundation Consumer Healthcare Recent Developments
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Cold Sore Treatment Introduction
11.4.4 Novartis Revenue in Cold Sore Treatment Business (2017-2022)
11.4.5 Novartis Recent Developments
11.5 Teva Pharmaceuticals
11.5.1 Teva Pharmaceuticals Company Details
11.5.2 Teva Pharmaceuticals Business Overview
11.5.3 Teva Pharmaceuticals Cold Sore Treatment Introduction
11.5.4 Teva Pharmaceuticals Revenue in Cold Sore Treatment Business (2017-2022)
11.5.5 Teva Pharmaceuticals Recent Developments
11.6 Amneal Pharmaceuticals LLC
11.6.1 Amneal Pharmaceuticals LLC Company Details
11.6.2 Amneal Pharmaceuticals LLC Business Overview
11.6.3 Amneal Pharmaceuticals LLC Cold Sore Treatment Introduction
11.6.4 Amneal Pharmaceuticals LLC Revenue in Cold Sore Treatment Business (2017-2022)
11.6.5 Amneal Pharmaceuticals LLC Recent Developments
11.7 AiCuris
11.7.1 AiCuris Company Details
11.7.2 AiCuris Business Overview
11.7.3 AiCuris Cold Sore Treatment Introduction
11.7.4 AiCuris Revenue in Cold Sore Treatment Business (2017-2022)
11.7.5 AiCuris Recent Developments
11.8 Apotex
11.8.1 Apotex Company Details
11.8.2 Apotex Business Overview
11.8.3 Apotex Cold Sore Treatment Introduction
11.8.4 Apotex Revenue in Cold Sore Treatment Business (2017-2022)
11.8.5 Apotex Recent Developments
11.9 Aurobindo Pharma USA, Inc.
11.9.1 Aurobindo Pharma USA, Inc. Company Details
11.9.2 Aurobindo Pharma USA, Inc. Business Overview
11.9.3 Aurobindo Pharma USA, Inc. Cold Sore Treatment Introduction
11.9.4 Aurobindo Pharma USA, Inc. Revenue in Cold Sore Treatment Business (2017-2022)
11.9.5 Aurobindo Pharma USA, Inc. Recent Developments
11.10 Cipla
11.10.1 Cipla Company Details
11.10.2 Cipla Business Overview
11.10.3 Cipla Cold Sore Treatment Introduction
11.10.4 Cipla Revenue in Cold Sore Treatment Business (2017-2022)
11.10.5 Cipla Recent Developments
11.11 Glenmark Pharmaceuticals, Inc.
11.11.1 Glenmark Pharmaceuticals, Inc. Company Details
11.11.2 Glenmark Pharmaceuticals, Inc. Business Overview
11.11.3 Glenmark Pharmaceuticals, Inc. Cold Sore Treatment Introduction
11.11.4 Glenmark Pharmaceuticals, Inc. Revenue in Cold Sore Treatment Business (2017-2022)
11.11.5 Glenmark Pharmaceuticals, Inc. Recent Developments
11.12 Hikma Pharmaceuticals
11.12.1 Hikma Pharmaceuticals Company Details
11.12.2 Hikma Pharmaceuticals Business Overview
11.12.3 Hikma Pharmaceuticals Cold Sore Treatment Introduction
11.12.4 Hikma Pharmaceuticals Revenue in Cold Sore Treatment Business (2017-2022)
11.12.5 Hikma Pharmaceuticals Recent Developments
11.13 HRA Pharma
11.13.1 HRA Pharma Company Details
11.13.2 HRA Pharma Business Overview
11.13.3 HRA Pharma Cold Sore Treatment Introduction
11.13.4 HRA Pharma Revenue in Cold Sore Treatment Business (2017-2022)
11.13.5 HRA Pharma Recent Developments
11.14 Hetero Healthcare Ltd
11.14.1 Hetero Healthcare Ltd Company Details
11.14.2 Hetero Healthcare Ltd Business Overview
11.14.3 Hetero Healthcare Ltd Cold Sore Treatment Introduction
11.14.4 Hetero Healthcare Ltd Revenue in Cold Sore Treatment Business (2017-2022)
11.14.5 Hetero Healthcare Ltd Recent Developments
11.15 Jubilant Cadista
11.15.1 Jubilant Cadista Company Details
11.15.2 Jubilant Cadista Business Overview
11.15.3 Jubilant Cadista Cold Sore Treatment Introduction
11.15.4 Jubilant Cadista Revenue in Cold Sore Treatment Business (2017-2022)
11.15.5 Jubilant Cadista Recent Developments
11.16 Merix Pharmaceutical Corp
11.16.1 Merix Pharmaceutical Corp Company Details
11.16.2 Merix Pharmaceutical Corp Business Overview
11.16.3 Merix Pharmaceutical Corp Cold Sore Treatment Introduction
11.16.4 Merix Pharmaceutical Corp Revenue in Cold Sore Treatment Business (2017-2022)
11.16.5 Merix Pharmaceutical Corp Recent Developments
11.17 Square
11.17.1 Square Company Details
11.17.2 Square Business Overview
11.17.3 Square Cold Sore Treatment Introduction
11.17.4 Square Revenue in Cold Sore Treatment Business (2017-2022)
11.17.5 Square Recent Developments
11.18 Sun Pharmaceutical Industries Ltd.
11.18.1 Sun Pharmaceutical Industries Ltd. Company Details
11.18.2 Sun Pharmaceutical Industries Ltd. Business Overview
11.18.3 Sun Pharmaceutical Industries Ltd. Cold Sore Treatment Introduction
11.18.4 Sun Pharmaceutical Industries Ltd. Revenue in Cold Sore Treatment Business (2017-2022)
11.18.5 Sun Pharmaceutical Industries Ltd. Recent Developments
11.19 Viatris
11.19.1 Viatris Company Details
11.19.2 Viatris Business Overview
11.19.3 Viatris Cold Sore Treatment Introduction
11.19.4 Viatris Revenue in Cold Sore Treatment Business (2017-2022)
11.19.5 Viatris Recent Developments
11.20 Wockhardt
11.20.1 Wockhardt Company Details
11.20.2 Wockhardt Business Overview
11.20.3 Wockhardt Cold Sore Treatment Introduction
11.20.4 Wockhardt Revenue in Cold Sore Treatment Business (2017-2022)
11.20.5 Wockhardt Recent Developments
11.21 Zydus Pharmaceuticals
11.21.1 Zydus Pharmaceuticals Company Details
11.21.2 Zydus Pharmaceuticals Business Overview
11.21.3 Zydus Pharmaceuticals Cold Sore Treatment Introduction
11.21.4 Zydus Pharmaceuticals Revenue in Cold Sore Treatment Business (2017-2022)
11.21.5 Zydus Pharmaceuticals Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 喉スプレーのグローバル市場展望 2023年-2029年：15ml、20ml、30ml
  • 眼がん治療の世界市場インサイト・予測（～2028年）
  • カタレプシー治療の世界市場インサイト・予測（～2028年）
  • 地図状萎縮治療の世界市場インサイト・予測（～2028年）
  • 防腐性口内炎リンスのグローバル市場展望 2023年-2029年：アルコール性、ノンアルコール性
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QY22JL3477 )"単純疱疹治療の世界市場インサイト・予測（～2028年）" (英文：Global Cold Sore Treatment Market Insights, Forecast to 2028)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。